Publicacións en colaboración con investigadores/as de Universidad Complutense de Madrid (151)

2024

  1. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer

  2. Chronic Obstructive Lung Disease: Treatment Guidelines and Recommendations for Referral and Multidisciplinary Continuity of Care

    Journal of Clinical Medicine, Vol. 13, Núm. 2

  3. Continuity of Care in Chronic Obstructive Pulmonary Disease Exacerbations: Challenges and Priorities

    Archivos de Bronconeumologia

  4. Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study

    International Journal of Cardiology, Vol. 401

  5. Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer’s disease

    GeroScience, Vol. 46, Núm. 3, pp. 2989-3003

  6. Patterns for optimizing post-acute myocardial infarction antiplatelet treatment

    REC: CardioClinics

  7. Prognostic Utility of Society for Cardiovascular Angiography and Interventions Shock Stage Approach for Classifying Cardiogenic Shock Severity in Takotsubo Syndrome

    Journal of the American Heart Association, Vol. 13, Núm. 6, pp. e032951

  8. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301

  9. Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 215-225

  10. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

    Pharmaceutics, Vol. 16, Núm. 5

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis

    Trends in Cardiovascular Medicine, Vol. 33, Núm. 5, pp. 319-326

  3. Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  4. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  5. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  6. Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  7. Heart failure in older patients with atrial fibrillation: incidence and risk factors

    Revista Espanola de Cardiologia

  8. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  9. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

    International Journal of Cardiology, Vol. 386, pp. 59-64

  10. Is it Reasonable to Start Bronchodilator Treatment Before Confirming the Diagnosis of COPD?

    Open Respiratory Archives